Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ftibamzone Liniment

Approval Number

国药准字H20003302

Company重庆科瑞制药（集团）有限公司

Registration Date

August 25, 2020

Previous Approval Numbers

国药准字H20003302

Drug Information

Generic Name

酞丁安搽剂

Brand Name

科瑞

Dosage Form

搽剂

Strength

5ml:25mg

Drug Type

化学药品

Registration Date

August 25, 2020

Company Information

Applicant Company

Company Name重庆科瑞制药（集团）有限公司

Company Address

重庆市南岸经济技术开发区大石支路2号

Manufacturing Company

Company Name重庆科瑞制药（集团）有限公司

Company Address

重庆市南岸经济技术开发区大石支路2号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy